Literature DB >> 33649321

Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study.

Zhuoer Xie1, Ahmad Nanaa1, Antoine N Saliba1, Rong He2, David Viswanatha3, Phuong Nguyen2, Dragan Jevremovic3, Patricia Greipp2, Mohamad E Salama2, Naseema Gangat1, Hassan B Alkhateeb1, Ayalew Tefferi1, Mark Litzow1, Mrinal Patnaik1, Mithun Shah1, Aref Al-Kali4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33649321      PMCID： PMC7921651          DOI： 10.1038/s41408-021-00439-x

Source DB:  PubMed          Journal:  Blood Cancer J        ISSN： 2044-5385            Impact factor:   11.037


× No keyword cloud information.
  11 in total

1.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

Authors:  David P Steensma; Rafael Bejar; Siddhartha Jaiswal; R Coleman Lindsley; Mikkael A Sekeres; Robert P Hasserjian; Benjamin L Ebert
Journal:  Blood       Date:  2015-04-30       Impact factor: 22.113

2.  Clinical significance of somatic mutation in unexplained blood cytopenia.

Authors:  Luca Malcovati; Anna Gallì; Erica Travaglino; Ilaria Ambaglio; Ettore Rizzo; Elisabetta Molteni; Chiara Elena; Virginia Valeria Ferretti; Silvia Catricalà; Elisa Bono; Gabriele Todisco; Antonio Bianchessi; Elisa Rumi; Silvia Zibellini; Daniela Pietra; Emanuela Boveri; Clara Camaschella; Daniela Toniolo; Elli Papaemmanuil; Seishi Ogawa; Mario Cazzola
Journal:  Blood       Date:  2017-04-19       Impact factor: 22.113

Review 3.  CHIP, ICUS, CCUS and other four-letter words.

Authors:  R Bejar
Journal:  Leukemia       Date:  2017-06-08       Impact factor: 11.528

4.  MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance.

Authors:  Brian Kwok; Jeff M Hall; John S Witte; Yin Xu; Prashanti Reddy; Keming Lin; Rachel Flamholz; Bashar Dabbas; Aine Yung; Jenan Al-Hafidh; Emily Balmert; Christine Vaupel; Carlos El Hader; Matthew J McGinniss; Shareef A Nahas; Julie Kines; Rafael Bejar
Journal:  Blood       Date:  2015-10-01       Impact factor: 22.113

5.  Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.

Authors:  Bruce D Cheson; Peter L Greenberg; John M Bennett; Bob Lowenberg; Pierre W Wijermans; Stephen D Nimer; Antonio Pinto; Miloslav Beran; Theo M de Witte; Richard M Stone; Moshe Mittelman; Guillermo F Sanz; Steven D Gore; Charles A Schiffer; Hagop Kantarjian
Journal:  Blood       Date:  2006-04-11       Impact factor: 22.113

Review 6.  Clinical Implications of Clonal Hematopoiesis.

Authors:  David P Steensma
Journal:  Mayo Clin Proc       Date:  2018-07-04       Impact factor: 7.616

Review 7.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

Authors:  Claudio Franceschi; Judith Campisi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-06       Impact factor: 6.053

Review 8.  SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.

Authors:  Luca Malcovati; Kristen Stevenson; Elli Papaemmanuil; Donna Neuberg; Rafael Bejar; Jacqueline Boultwood; David T Bowen; Peter J Campbell; Benjamin L Ebert; Pierre Fenaux; Torsten Haferlach; Michael Heuser; Joop H Jansen; Rami S Komrokji; Jaroslaw P Maciejewski; Matthew J Walter; Michaela Fontenay; Guillermo Garcia-Manero; Timothy A Graubert; Aly Karsan; Manja Meggendorfer; Andrea Pellagatti; David A Sallman; Michael R Savona; Mikkael A Sekeres; David P Steensma; Sudhir Tauro; Felicitas Thol; Paresh Vyas; Arjan A Van de Loosdrecht; Detlef Haase; Heinz Tüchler; Peter L Greenberg; Seishi Ogawa; Eva Hellstrom-Lindberg; Mario Cazzola
Journal:  Blood       Date:  2020-07-09       Impact factor: 25.476

9.  Age-related mutations associated with clonal hematopoietic expansion and malignancies.

Authors:  Mingchao Xie; Charles Lu; Jiayin Wang; Michael D McLellan; Kimberly J Johnson; Michael C Wendl; Joshua F McMichael; Heather K Schmidt; Venkata Yellapantula; Christopher A Miller; Bradley A Ozenberger; John S Welch; Daniel C Link; Matthew J Walter; Elaine R Mardis; John F Dipersio; Feng Chen; Richard K Wilson; Timothy J Ley; Li Ding
Journal:  Nat Med       Date:  2014-10-19       Impact factor: 53.440

10.  Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis.

Authors:  Rong He; Daniel J Devine; Zheng Jin Tu; Ming Mai; Dong Chen; Phuong L Nguyen; Jennifer L Oliveira; James D Hoyer; Kaaren K Reichard; Paul L Ollila; Aref Al-Kali; Ayalew Tefferi; Kebede H Begna; Mrinal M Patnaik; Hassan Alkhateeb; David S Viswanatha
Journal:  Mod Pathol       Date:  2019-08-30       Impact factor: 7.842
View more
  3 in total

Review 1.  Emerging immuno-oncology targets in Myelodysplastic Syndromes (MDS).

Authors:  Michael Mann; Andrew M Brunner
Journal:  Curr Probl Cancer       Date:  2021-12-26       Impact factor: 3.187

Review 2.  When are idiopathic and clonal cytopenias of unknown significance (ICUS or CCUS)?

Authors:  Afaf E W G Osman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 3.  Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-09-01       Impact factor: 3.122
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.